biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Biodexa's CEO

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Dec 21, 2022 10:38pm

134 Views

Post# 35186280

RE:RE:RE:Biodexa's CEO

Yo, craig, the Bioasis shareholders have lost millions, some individuals having lost that much and more. It's not "hundreds of thousands of $" as you say.

My interest lies with the shareholoders. Always has, which has always kept me just off the Bioasis Christmas card list.

You, you're only interested in me. No matter how bad things are for the shareholders, you're focused on me, obsessed, actually.

Would you like me to put a personal item of some sort in a sealed wrapper and courier it to you? Would that help? If I had it embroidered with shareholder monograms, would that help you think of them, instead of me?

JD Boomskid

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth